Listen and Watch Recorded

March 2012 Radio Shows

 

March 29, 2012 Where To Invest Radio Show 

Listen to Show Recording: http://billchippasshow.com/2012/bcshow03292012.mp3  

Watch Show Recording: http://www.ustream.tv/recorded/21451530 

The Bill Chippas Investing News Radio Show featured Terry Howlett, CEO of Skinvisible Inc. (Stock Symbol: SKVI). Skinvisible Pharmaceuticals (http://www.skinvisible.com) is a research-and-development company that licenses its proprietary formulations made with Invisicare®, its’ patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. 

Skinvisible’s value lies in its ability to continually generate new Intellectual Property on dermatology and medical products formulated with Invisicare®. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare® patent.

 

Rule 17B Requirements — Disclosure of Payment for Investor Relations–Princeton Research has received 150,000 restricted shares from Skinvisible in exchange for investor relations services.

 

Entertainment Apps News

The show also featured William Schonbrun, CEO of Bitzio Inc (Symbol: BTZO). Bitzio (http://www.bitzio.com/) focuses on developing entertainment-based mobile applications for smartphones. 

Bitzio can launch products, acquire, build and integrate businesses, build mobile Apps and maximize revenue and profits. Bitzio provides an application network for developers and consumers of mobile applications to enhance their marketing reach, sales conversion, revenue, and bottom line profits.

Bitzio, Inc. is based in San Francisco, California and aims to be responsible for the download of 1 Billion apps by 2014.  William Schonbrun has over 20 years of executive leadership experience driving the start-up, growth and optimization of diverse businesses within the technology, management consulting and marketing industries.

 

March 27, 2012 Where To Invest Radio Show

Listen to Show Recording: http://billchippasshow.com/2012/bcshow03272012.mp3

The Bill Chippas Investing News Radio Show featured Craig Crawford, VP of Texas Gulf Energy (Stocks Symbol: TXGE).

A new microcap energy industry stock, Texas Gulf Energy, Inc. (See http://www.tgnrg.com) is headquartered in the energy capital of the world, Houston, Texas. Its’ strategic partner is Industrial Maintenance International (IMI), located in Tunis, Tunisia. IMI is a Joint Venture partner with Texas Gulf Energy, shares the same majority shareholders and represents Texas Gulf Energy through IMI offices in 23 countries globally.

Major international energy companies including Exxon Mobil, Conoco Phillips, Chevron, Valero, and others have utilized Texas Gulf Energy to complete major projects safely, on time and on budget.

For more information please visit the company website at www.tgnrg.com or 

Call Princeton Research at 702-850-3000 

Rule 17B Requirements Disclosure – Princeton Research and or it’s principles own shares in Texas Gulf Energy.

 

March 22, 2012 Where To Invest Radio Show

Watch Show Recording: http://www.ustream.tv/recorded/21289199

Listen to Show Recording: http://billchippasshow.com/2012/bcshow03222012.mp3

The Bill Chippas Investing News Radio Show featured Kenneth Bosket, CEO of Crown Tele Services, Inc. (Symbol: CRWE). See http://crownteleservices.com

Mr. Bosket has over 30 years of experience with Sprint before retiring as upper management in December, 2005. Serving as Sprint’s Western Division Facilitator brings experience in building team dynamics and group skills. Mr. Bosket earned a Masters of Business Administration from the University of Phoenix and a Bachelor’s of Business Administration from National University. 

Crown TeleServices provides simple Unified Communications (UC) solutions for business phone systems and residential use .Crown offers local and long distance rates at huge discounts with crystal clear quality.

International long distance, local, toll free, call centers and more – Crown delivers a system designed to be as easily managed as it is to deploy and use. Along with its low total cost of ownership, a Crown TeleServices UC system helps organizations leverage their most valuable assets: people and information. Crown’s offers a brilliantly simple solution to replace old phone systems, upgrade to unified communications, or to modernize contact centers.

 

March 20, 2012 Where To Invest Radio Show

Watch Show Recording: http://www.ustream.tv/recorded/21239686 

Listen to Show Recording: http://billchippasshow.com/2012/bcshow03202012.mp3

The Bill Chippas Investing News Radio Show featured Joe Salvani with IntelliCell (Symbol: SVFC).

IntelliCell BioSciences (See www.intellicellbiosciences.com) is a pioneering regenerative medicine company focused on the expanding regenerative medical markets.

The Intellicell procedure has the support and backing of the leading orthopedic surgeons in sports medicine. Dr. James Andrews, who is known for his “Tommy John surgery” procedure is on the Medical Advisory Board.

IntelliCell BioSciences is setting up ‘Centers of Excellence’ where doctors can treat their patients and is focusing on selling laboratory suites and licensing its technology to doctors for use in their offices.

The applications for its product target the wide and diverse regenerative, preventative, and curative medical market including sports related injuries.

For more information read the Princeton Research
IntelliCell BioSciences Inc. March 2012 Report – http://www.princetonresearch.com/Intellicell-3-2012.pdf 

Visit the company website at http://www.intellicellbiosciences.com

 

Rule 17B Requirements — Disclosure of Payment for Investor Relations– Princeton Research has contracted to receive 10,000 restricted shares from IntelliCell BioSciences for investor relations.

 

March 15, 2012 Where To Invest Radio Show

The Bill Chippas Investing News Radio Show featured Joe Salvani and IntelliCell BioSciences, Inc. (SVFC).  IntelliCell BioSciences (http://www.intellicellbiosciences.com) is a pioneering regenerative medicine company. IntelliCell BioSciences Inc. offers Intellicell™, a treatment for the correction of lines, wrinkles, and dermal defects, as well as for various treatments, including anti-aging, scarring, burns, and non-healing wounds, osteoarthritis, cartilage and general dermal regeneration.

The applications for its product are wide and diverse. IntelliCell BioSciences, Inc. is based in New York, New York. IntelliCell intends to initially focus on selling laboratory suites and licensing its technology to doctors for use in their offices for their patients. The company is also setting up Centers of Excellence where doctors can treat their patients.

Read the Intellicell March 2012 Research Report:

http://www.princetonresearch.com/Intellicell-3-2012.pdf

For additional information:

Stock Quote and Trading Chart: http://www.intellicellbiosciences.com/investor-relations.html

Visit http://www.intellicellbiosciences.com or

Call Princeton Research at 702-650-3000

 

We also interviewed Mark Lunden, CEO of The Guitammer Company Inc. (GTMM).

Website :http://shakemycouch.com and http://www.thebuttkicker.com  
Guitammer engages in the research, development, manufacture, and sale of low frequency audio transducers in the United States and internationally.

The company sells its products for use in home theater, gaming, and car audio; by musicians and professional audio technicians; and in amusement parks and theater markets. It offers ButtKicker LIVE!, a patented broadcast technology for various sporting events to broadcast along with the sound and video. The company was incorporated in 1990 and is based in Westerville, Ohio.

It’s ‘ButtKicker ‘ brand transducers, which provide the vibration or bass effects; various models of amplifiers; and accessories necessary to facilitate the use of its products, as well as silent subwoofers for Car Audio brand transducers. Its product portfolio includes wireless ButtKicker kits for use in home theater and gaming applications; and ButtKicker gamers for gaming use in PCs and game consoles, which enables the user to feel gunshots, explosions, and special effects of video games, as well as the bass beat for music.   

Investors Information:

http://www.thebuttkicker.com/investors/index.htm

 

Rule 17B Requirements – Disclosure of Payment for Investor Relations – Princeton Research has contracted to receive 10,000 restricted shares from IntelliCell BioSciences for investor relations.

Watch Show Recording: http://www.ustream.tv/recorded/21128538

Listen to Show Recording: http://billchippasshow.com/2012/bcshow03152012.mp3

 

March 13, 2012 – Where To Invest Investment News Radio Show 

The Bill Chippas Investing News Radio Show featured David Mathews, CEO of Texas Gulf Energy (TXGE). Texas Gulf Energy (http://www.tgnrg.com/)  is located in the energy capital of the world Houston, Texas, major international energy companies including Exxon Mobil, Conoco Phillips, Chevron, Valero, and others have utilized Texas Gulf Energy to complete major projects.It’s strategic partner is Industrial Maintenance International (IMI), located in Tunis, Tunisia.

David Mathews CEO of Texas Gulf Energy successfully built Inserv Construction Services in Houston from start-up mode into an industry powerhouse in only four years. Mr. Mathews and the Inserv partners then successfully sold Inserv for approximately $226,000,000 in 2007.

Observing many of the same industry conditions in 2011 that existed before Inserv Construction Services was built, David Mathews has reassembled the key members of this same team to build Texas Gulf Energy Inc

Industrial Maintenance International (IMI) is a Joint Venture partner with Texas Gulf Energy  represents Texas Gulf Energy through IMI offices in twenty three countries globally.

Research Report on Texas Gulf Energy 
Company website is http://www.TGNRG.com   

*Rule 17B Requirements — Disclosure – Princeton Research and or it’s principles own shares in Texas Gulf Energy.

Watch Show Recording: http://www.ustream.tv/recorded/21081266

Listen to Show Recording: http://billchippasshow.com/2012/bcshow03132012.mp3

 

March 1, 2012 Investing News Radio Show

The Bill Chippas Investing News Radio Show featured IntelliCell BioSciences, Inc. (Symbol SVFC), a pioneering regenerative medicine company focused on the expanding regenerative medical markets, and Texas Gulf Energy, Inc. (Symbol: BOCL).

IntelliCell BioSciences develops a portfolio of products and services that targets a wide and diverse regenerative, preventative, and curative medical market including age related disease states to sports related injuries.

IntelliCell’s process is a patent-pending non-enzymatic method for deriving stromal vascular fraction from adipose tissue (your own fat).  IntelliCell’s process dramatically increases the yield by 10 to 20 times in manufacturing compared to methods in use today. These mixtures of cells have multiple functions and are highly integrated and it’s likely, more potent than the adipose stem cells by themselves.

IntelliCell BioSciences Inc.  offers Intellicell™, a treatment for the correction of lines, wrinkles, and dermal defects, as well as for various treatments, including anti-aging, scarring, burns, and non-healing wounds; stem cell product candidates for treating aging dermal skin; and product candidates in the areas of osteoarthritis, cartilage and meniscus regeneration, and general dermal regeneration, the applications for its product are wide and diverse,

IntelliCell BioSciences, Inc. is based in New York, New York.IntelliCell intends to initially focus on selling laboratory suites and licensing its technology to doctors for use in their offices for their patients. The company is also setting up Centers of Excellence where doctors can treat their patients. 

IntelliCell announced last month it licensed its proprietary, patent pending technology to RegenaStem Inc., a Canadian Federally Incorporated Company, with offices in Ontario, The license calls for investing a minimum of $500,000 to a maximum of $1.5 million into IntelliCell BioSciences and paying royalties of 30% of net revenue.The company is also starting FDA IND clinical trials at major medical centers for clinical indication approval, some potential centers are; Emory, Georgia Tech, Mt Sinai Medical Center , NYU and Tulane.  IntelliCell intends to pursue expansion to secondary markets and beyond the U.S. through a combination of company-owned and licensed clinical facilities.

For additional information, visit http://www.intellicellbiosciences.com or call Princeton Research at 702-650-3000

 

Return To Investing Talk Radio Shows

Main Page – Click Here

 

Hear Past Show Recordings

Visit March 2012 Shows Page

http://www.princetonresearch.com/investment-news-radio-shows-from-march-2012/

 

Visit February and January 2012

Archive Pages

 http://www.princetonresearch.com/investing-news-radio-shows-february-and-january-2012/

 

Hear Past Show Recordings

Visit the 2011, 2010 Archives Pages

http://www.princetonresearch.com/where-to-invest-radio-show-recordings-2011/